Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Taylor Sandison Insider Profile
4 Followers
Taylor Sandison, CMO at Cidara Therapeutics, holds 475.85K shares in Cidara Therapeutics (Ticker: CDTX).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-14.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Taylor Sandison's holdings
Insider Roles
CMO
Roles that Taylor Sandison holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 08, 2017 - Jun 08, 2018
Return:-12.10%
The most profitable trade made by Taylor Sandison
Taylor Sandison's Trading History
List of latest transactions for each holding click on a transaction to see Taylor Sandison's performance on stock
You May Also Like
Taylor Sandison insider profile FAQ
What is the percentage of profitable transactions made by Taylor Sandison?
The percentage of profitable transactions made by Taylor Sandison is 0%.
What is the average return per transaction made by Taylor Sandison?
The average return per transaction made by Taylor Sandison is -14.70%.
What stocks does Taylor Sandison hold?
Taylor Sandison holds: CDTX stocks.
What was Taylor Sandison’s latest transaction?
Taylor Sandison latest transaction was an Uninformative Buy of ―.
What was Taylor Sandison's most profitable transaction?
Taylor Sandison’s most profitable transaction was an Informative Buy of CDTX stock on June 8, 2017. The return on the trade was -12.10%.
What is Taylor Sandison's role in Cidara Therapeutics?
Taylor Sandison's role in Cidara Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.